Keywords: UK, NICE, Alzheimer's, Eisai, Aricept, Shire, Reminyl, Novartis, Exelon, Lundbeck, Ebixa, Merck & Co, Johnson & Johnson, Simponi

UK’s NICE does about turn on Alzheimer’s drugs but unable to recommend Merck & Co/J&J’s psoriatic arthritis drug Simponi

Article | 07 October 2010

Print This

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) this morning announced new draft guidance which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in